BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8504995)

  • 1. Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages.
    O'Brien ME; Schofield JB; Tan S; Fryatt I; Fisher C; Wiltshaw E
    Gynecol Oncol; 1993 May; 49(2):250-4. PubMed ID: 8504995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors].
    Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M
    Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Survival of cervical cancer patients in selected regions of Poland in 1990-1996, in relation to some prognostic factors].
    Bielska-Lasota M; Krynicki R; Rabczenko D; Czerw-Głab K; Starzewski J; Wronkowski Z; Zieliński J; Chil A; Hudała-Klecha J; Swiercz A
    Przegl Epidemiol; 2004; 58(3):523-36. PubMed ID: 15730017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
    Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor.
    Massi D; Susini T; Savino L; Boddi V; Amunni G; Colafranceschi M
    Cancer; 1996 Mar; 77(6):1131-6. PubMed ID: 8635134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of ovarian cancer patients who underwent incomplete surgical staging.
    Panprom P; Lertkhachonsuk R
    J Med Assoc Thai; 2008 Sep; 91(9):1323-30. PubMed ID: 18843859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study.
    Akahira JI; Yoshikawa H; Shimizu Y; Tsunematsu R; Hirakawa T; Kuramoto H; Shiromizu K; Kuzuya K; Kamura T; Kikuchi Y; Kodama S; Yamamoto K; Sato S
    Gynecol Oncol; 2001 Jun; 81(3):398-403. PubMed ID: 11371128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
    Erzen M; Rakar S; Klancnik B; Syrjänen K
    Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of lymphadenectomy and survival in stage I ovarian cancer patients.
    Chan JK; Munro EG; Cheung MK; Husain A; Teng NN; Berek JS; Osann K
    Obstet Gynecol; 2007 Jan; 109(1):12-9. PubMed ID: 17197582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage IV ovarian cancer: prognostic factors and survival beyond 5 years.
    Scholz HS; Benedicic C; Haas J; Tamussino K; Petru E
    Anticancer Res; 2001; 21(5):3729-32. PubMed ID: 11848553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic correlates of progression-free interval and survival in ovarian clear cell adenocarcinoma.
    Kennedy AW; Biscotti CV; Hart WR; Tuason LJ
    Gynecol Oncol; 1993 Sep; 50(3):334-8. PubMed ID: 8406197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment and prognostic factors for stage IV epithelial ovarian cancer].
    Wu M; Shen K; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors in granulosa cell tumor of the ovary].
    Wu L; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Nov; 35(11):673-6. PubMed ID: 11218897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.